openPR Logo
Press release

What's Driving The Human platelet lysate market? Prominent Players - SCLAVO Diagnostics International, ZenBio, STEMCELL Technologies, Cook Medical, Macopharma, Merck KGaA, Darmstadt, Germany

What's Driving The Human platelet lysate market? Prominent

Increased emphasis on funding and rise in research centers, product innovation, clinical and staff efficiency, government regulations and user acceptance are the major driving factors fueling the growth of the human platelet lysate market during the forecast period. Growing awareness levels of blood donation and adoption of advanced blood collection and processing technology in emerging countries is also expected to boost the human platelet lysate market. In addition, a large donated blood pool in most of the developed countries is expected to fuel the demand for human platelet lysate (HPL) products over the forecast period. HPL are a convenient alternative to Fetal Bovine Serum (FBS) as an in-vitro cell culture growth supplement and are likely to be adopted extensively in the near future for various therapeutic applications. Moreover, human platelet lysate has emerged as a boom for cell manufacturing in cell- based therapeutics. Further, the rising demand for animal free serum media is anticipated to boost revenue growth of the Human Platelet Lysate market during the forecast period.

Get Sample Copy of This Report@ https://www.persistencemarketresearch.com/samples/16789

According to a new study published by Persistence Market Research (PMR), the global human platelet lysate market is estimated to be valued at US$ 45.8 Mn in 2018 and is expected to expand at a CAGR of 3.6% over 2018–2026, to reach US$ 61.0 Mn by 2026 end. Based on Application, the Clinical Use segment clearly dominates the global Human Platelet Lysate market, with over 93.5% value share in 2017. This segment is expected to grow at 3.7% CAGR over the forecast period of 2018-2026.

The global human platelet lysate market has been segmented on the basis of product, application, end user and region. Globally, Heparin-free Platelet Lysate and Platelet Lysate with Heparin both show lucrative market attractiveness. The Heparin-free Platelet Lysate segment is expected to be slightly more lucrative and is estimated to contribute 50.8% value share in the global human platelet lysate market during the forecast period. Among all end users of Human Platelet Lysate products, research and academic institutes are expected to be the most lucrative, given the increasing acceptance of Human Platelet Lysate products by the research fraternity. With nearly 37.7% market share, North America dominated the global Human Platelet Lysate market in 2017, partly due to increasing research and development activities, particularly stem cell and biopharmaceuticals especially in the United States.

Key Research Findings

• Funding for Life Science research and investments in this area serves to expand various projects undertaken and personnel employed. Sources of R&D spending include governments, private funding or commercial organizations

• Academic research institutes have focused on advanced research, including applied research when government or industrial organizations prefer cost-effective ways to pursue development programs. A majority of basic research continues to be carried out at academia as companies focus on bringing products to the market with an eye towards generating profits

• Matured markets of North America and Europe collectively held 67.5% value share in the global Human Platelet Lysate market in 2017

• Individual share of the regional market in Europe is expected to decline over time, partly due to the economic downturn in the European Union. However, revenue from the matured markets in the EU will continue to grow with a collective growth share of 69.5% over the forecast period

• In several countries, Human Platelet Lysate products such Heparin-free Platelet Lysate and Platelet Lysate with Heparin are dispensed through direct sales channels to research and academic institutes, cell therapy providers, and biopharmaceutical companies. Research and academic institutes dominated the global market for Human Platelet Lysate in 2017 and are expected to gain market share during the forecast period

Request For Methodology @ https://www.persistencemarketresearch.com/methodology/16789

6. North America Human Platelet Lysate Market Analysis 2013–2017 and Forecast 2018–2026
6.1. Introduction
6.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017
6.2.1. U.S.
6.2.2. Canada
6.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
6.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
6.4.1. Heparin-free Platelet Lysate
6.4.2. Platelet Lysate with Heparin

6.5. Market Size (US$ Mn) and Forecast By Product Type, 2018–2026
6.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
6.6.1. Research Use
6.6.2. Clinical Use
6.7. Market Size (US$ Mn) Forecast By Application, 2018–2026
6.8. Historical Market Size (US$ Mn) Analysis By End User, 2013–2017
6.8.1. Academic & Research Institutes
6.8.2. Biopharmaceutical Companies

6.8.3. Others
6.9. Market Size (US$ Mn) Forecast By End User, 2018–2026
6.10. Market Attractiveness Analysis
6.10.1. By Country
6.10.2. By Product Type
6.10.3. By Application
6.10.4. By End User
6.11. Drivers and Restraints – Impact Analysis

7. Latin America Human Platelet Lysate Market Analysis 2013–2017 and Forecast 2018–2026
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Trends Analysis By Country, 2012–2016
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
7.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
7.4.1. Heparin-free Platelet Lysate

7.4.2. Platelet Lysate with Heparin
7.5. Market Size (US$ Mn) and Forecast By Product Type, 2018–2026
7.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
7.6.1. Research Use
7.6.2. Clinical Use
7.7. Market Size (US$ Mn) Forecast By Application, 2018–2026
7.8. Historical Market Size (US$ Mn) Analysis By End User, 2013–2017
7.8.1. Academic & Research Institutes
7.8.2. Biopharmaceutical Companies
7.8.3. Others

7.9. Market Size (US$ Mn) Forecast By End User, 2018–2026
7.10. Market Attractiveness Analysis
7.10.1. By Country
7.10.2. By Product Type
7.10.3. By Application
7.10.4. By End User
7.11. Drivers and Restraints – Impact Analysis

8. Europe Human Platelet Lysate Market Analysis 2013–2017 and Forecast 2018–2026
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
8.2.1. Germany
8.2.2. U.K.
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe

8.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
8.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
8.4.1. Heparin-free Platelet Lysate
8.4.2. Platelet Lysate with Heparin
8.5. Market Size (US$ Mn) and Forecast By Product Type, 2018–2026
8.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017

Full Report@ https://www.persistencemarketresearch.com/market-research/human-platelet-lysate-market.asp

ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's Driving The Human platelet lysate market? Prominent Players - SCLAVO Diagnostics International, ZenBio, STEMCELL Technologies, Cook Medical, Macopharma, Merck KGaA, Darmstadt, Germany here

News-ID: 1792997 • Views:

More Releases from persistencemarketresearch.com

Innovation-Based Discernment To Drive The Foil Shavers Market
Innovation-Based Discernment To Drive The Foil Shavers Market
Personal appearance has taken paramount importance in the lives of consumers. Proper grooming and professional appearance have become important attributes to gain respect at the workplace. The way people carry themselves creates an impression on co-workers and the management. The pressure and interest of looking good is equally important to both, men and women. Variations offered by trimmers and shavers have taken up the onus to drive the foil shavers
Alcoholic Hepatitis Therapeutic Market Rugged Expansion Foreseen by 2017 to 2025
Alcoholic Hepatitis Therapeutic Market Rugged Expansion Foreseen by 2017 to 2025
Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually occur in 30% of long- time alcohol drinkers. Asymptomatic steatohepatitis is also as alcoholic hepatitis the term is
Advanced Meniscal Fixation Devices Market Continuing to Show Billion Dollar Growth According to 'Persistence Market Research'
Advanced Meniscal Fixation Devices Market Continuing to Show Billion Dollar Grow …
Meniscal fixation is minimally invasive surgical procedure is used to reconstruct torn meniscus. Meniscus functions include distribution and load transmission, joint stability, neuromuscular proprioception and joint nutrition. Meniscal tears are symptomatic and irreparable and meniscal fixation devices are used to remove unstable fragments. Meniscal repair is performed only during longitudinal tears (>10 mm), tears without deformity or secondary degeneration, and others. Meniscal fixation devices are used arthroscopic repair or
Liniments Rubs Market segmentation by key players - Liniments & Rubs Market are Haw Par Corporation Limited., Procter & Gamble, GSK group of companies, Amrutanjan Health Care Ltd. and others. The companies are mainly focusing on intense marketing to conve
Liniments Rubs Market segmentation by key players - Liniments & Rubs Market are …
Liniments are liquid dosage forms which are used relieve pain and stiffness during arthritis, sore muscular aches, and muscle strains. Liniments & rubs are well absorbed through the skin and have a high bioavailability. Liniment vehicles depend on the type of action (counterirritants, massage, and rubefacient) and solubility of desired compounds. They can be used as irritants, analgesics, anti-inflammatory, astringents, and fungicidal. Rubefacient liniments are used for vasodilation and hyperthermia

All 5 Releases


More Releases for Platelet

Global Platelet aggregation reagents Market Growth 2019-2024
Market Research Report Store offers a latest published report on Platelet aggregation reagents Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Platelet aggregation reagents players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.To analyze the Platelet aggregation reagents with
Platelet, Plasma Market
Platelet, Plasma Market is estimated to surpass $ 6.3 Billion markets in 2019 and reach USD 14.56 Billion by 2024, at a Compound Annual Growth Rate (CAGR) of 3.2% during the forecast period 2016-2024 globally. For More Information Visit https://www.maximizemarketresearch.com/market-report/platelet-plasma-market/11293/ A rising incidence of haemophilia, thrombocytopenia, autoimmune diseases as well as other infectious and rare disease will serve to be a key driver for the platelet and plasma market growth. According
Platelet Rich Plasma Market By PRP Type (Pure-PRP, Leucocyte Rich PRP, Pure Plat …
Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contains bio proteins that helps in healing, tissue regeneration, and blood loss. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. The use of platelet rich plasma therapy is tremendously increased after 2009 due to its
Platelet Agitator Market - Speculation Exploration Report 2027
The report for Platelet Agitator Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The platelet agitator is used for safe and reliable storage of platelets under controlled environment. Platelet agitators are used to keep the platelets under continuous gentle
Platelet Agitator Market new booming trends in 2027
Market Research Future.com add new report of “Platelet Agitator Market Research Report – Global Forecast To 2027” it contains Company information, geographical data and Table of Content Platelet Agitator Market Information, by type (Flatbed, Circular and Combination devices), by capacity (small, medium and large) by end user (autonomous blood banks, hospital based blood banks and others) - Forecast to 2027 The platelet agitator is used for safe and reliable storage of
10-11-2017 | Health & Medicine
TMR
Platelet Rich Plasma Market Size, Share, Analysis & Forecast
With a larger pool of players operating domestically and a smaller bunch of international participants, the global platelet-rich plasma (PRP) market demonstrates a semi-consolidated landscape. The top five players, namely, Harvest Technologies, Arthrex Inc., Zimmer Biomet, DePuy Synthes, and Stryker Corp. accounted for more than 80% of this market in 2015. Most of these are headquartered in North America. However, their focus is likely to shift towards emerging economies across Asia Pacific